SenesTech, Inc.SNESEarnings & Financial Report
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
SNES Q4 2025 Key Financial Metrics
Revenue
$421.0K
Gross Profit
$233.0K
Operating Profit
$-1.9M
Net Profit
$-1.8M
Gross Margin
55.3%
Operating Margin
-446.8%
Net Margin
-428.5%
YoY Growth
-16.0%
EPS
$0.48
Financial Flow
SenesTech, Inc. Q4 2025 Financial Summary
SenesTech, Inc. reported revenue of $421.0K (down 16.0% YoY) for Q4 2025, with a net profit of $-1.8M (down 43.7% YoY) (-428.5% margin). Cost of goods sold was $188.0K, operating expenses totaled $2.1M.
Key Financial Metrics
| Total Revenue | $421.0K |
|---|---|
| Net Profit | $-1.8M |
| Gross Margin | 55.3% |
| Operating Margin | -446.8% |
| Report Period | Q4 2025 |
SenesTech, Inc. Annual Revenue by Year
SenesTech, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.2M). Click any linked year to see what changed vs the prior annual report.
SenesTech, Inc. Quarterly Revenue & Net Profit History
SenesTech, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $421.0K | -16.0% | $-1.8M | -428.5% |
| Q3 2025 | $690.0K | +43.2% | $-1.3M | -188.1% |
| Q2 2025 | $625.0K | +36.2% | $-1.6M | -258.6% |
| Q1 2025 | $485.0K | +16.9% | $-1.7M | -343.3% |
| Q4 2024 | $501.0K | +69.8% | $-1.3M | -250.5% |
| Q3 2024 | $482.0K | +33.9% | $-1.5M | -313.9% |
| Q2 2024 | $459.0K | +50.5% | $-1.6M | -345.1% |
| Q1 2024 | $415.0K | +78.1% | $-1.8M | -441.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $415000 | $459000 | $482000 | $501000 | $485000 | $625000 | $690000 | $421000 |
| YoY Growth | 78.1% | 50.5% | 33.9% | 69.8% | 16.9% | 36.2% | 43.2% | -16.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $5.5M | $4.0M | $4.4M | $3.3M | $3.6M | $10.4M | $14.6M | $12.8M |
| Liabilities | $862000 | $923000 | $798000 | $767000 | $734000 | $3.4M | $3.3M | $3.3M |
| Equity | $4.6M | $3.1M | $3.7M | $2.5M | $2.9M | $7.0M | $11.3M | $9.6M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.8M | $-1.6M | $-1.4M | $-1.2M | $-1.6M | $-1.1M | $-1.4M | $-1.7M |